使用Marlex网进行伸膝装置重建:77例全膝关节置换术的系列研究
该研究在单中心回顾了2000至2015年间77例因全膝关节置换术后伸膝装置断裂而使用Marlex网重建的患者,平均随访4年,84%的重建物在位,伸膝迟滞平均改善26°,功能结果优良,但需延长随访。
要点
- 77例全膝关节置换术后伸膝装置断裂患者使用Marlex网重建,平均随访4年时84%的重建物在位。
- 12例需行网片翻修,2年免于翻修生存率无既往重建者为86%,有既往非Marlex重建者为95%。
- 膝关节协会评分显著改善(p < 0.001),伸膝迟滞平均改善26°,术后平均9°(p < 0.001)。
核心结论
- 使用Marlex网重建全膝关节置换术后灾难性伸膝装置断裂是可行选择,平均随访4年时84%重建物在位,功能结果优良,伸膝迟滞平均改善26°。
- 需要延长随访,但这一平均随访4年的大系列结果令人鼓舞。
研究设计与样本
- 2000年至2015年在单中心三级学术机构开展的系列研究,纳入77例患者(77例全膝关节置换术)因伸膝装置断裂接受Marlex网重建。
- 伸膝装置断裂类型包括27例股四头肌腱断裂、40例髌腱断裂和10例髌骨骨折。
- 重建时平均年龄65岁,70%为女性,平均体重指数35 kg/m,平均随访4年。
- 18例(23%)在初次全膝关节置换术时原位行网片重建,59例(77%)在翻修全膝关节置换术时行网片重建,断裂至重建平均时间7个月,20例(26%)曾在外院尝试伸膝装置重建。
主要发现
- 77例网片重建中65例在末次随访时在位,12例失败需行网片翻修:5例髌腱断裂、5例股四头肌腱断裂、2例症状性延长。
- 另有4例网片失败患者采用支具非手术治疗。
- 无既往重建患者2年免于网片翻修生存率为86%,有既往非Marlex网伸膝装置重建患者为95%。
- 重建后膝关节协会评分显著改善(p < 0.001),伸膝迟滞平均改善26°,术后平均伸膝迟滞9°(p < 0.001)。
关键数值与推荐
- 无既往重建患者2年免于网片翻修生存率为86%,有既往非Marlex网伸膝装置重建患者为95%。
- 重建后膝关节协会评分显著改善(p < 0.001),伸膝迟滞平均改善26°,术后平均9°(p < 0.001)。
- 证据等级:治疗性IV级。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要延长随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Disruption of the extensor mechanism after total knee arthroplasty (TKA) is debilitating, and the reported results of numerous reconstructive options have varied. We previously reported the early results of 13 patients who underwent reconstruction of the extensor mechanism with use of Marlex mesh. The purpose of the current study was to assess results in a larger cohort of patients, with an emphasis on the survivorship of the mesh, clinical results, and complications. METHODS: During the period of 2000 to 2015 at a single tertiary care academic institution, 77 patients (77 TKAs) underwent reconstruction with use of Marlex mesh for an extensor mechanism disruption (27 quadriceps tendon disruptions, 40 patellar tendon disruptions, and 10 patellar fractures). The mean patient age at the time of reconstruction was 65 years; 70% of the patients were female. The mean body mass index was 35 kg/m. The mean follow-up was 4 years. Eighteen (23%) of the patients underwent mesh reconstruction with the primary TKA in place, and 59 (77%) had mesh reconstruction at the time of revision TKA. The mean time between disruption and reconstruction was 7 months. Twenty (26%) of the patients had previously undergone attempted extensor mechanism reconstruction at outside institutions. RESULTS: Sixty-five of the 77 mesh reconstructions were in place at the time of the latest follow-up. Twelve patients experienced a failure that required mesh revision: 5 for patellar tendon rupture, 5 for quadriceps tendon rupture, and 2 for symptomatic lengthening. Four additional patients with mesh failure were treated nonoperatively with bracing. The 2-year survivorship free of mesh revision was 86% for patients with no prior reconstruction and 95% for patients with previous reconstructions of the extensor mechanism that did not involve Marlex mesh. Knee Society Score (KSS) results significantly improved following reconstruction (p < 0.001). Extensor lag improved by a mean of 26°, with mean postoperative extensor lag measuring 9° (p < 0.001). CONCLUSIONS: Reconstruction of the extensor mechanism with use of Marlex mesh is a viable option in patients with catastrophic disruption after TKA. At the time of the latest follow-up, 84% of the mesh reconstructions were in place and the functional outcomes were excellent, with mean improvement in extensor lag of 26°. Extended follow-up is required, but the results of this large series with a mean follow-up of 4 years are encouraging. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Abdel MP, Salib CG, Mara KC, et al. Extensor Mechanism Reconstruction with Use of Marlex Mesh: A Series Study of 77 Total Knee Arthroplasties. J Bone Joint Surg Am. 2018. PMID: 30063593. doi:10.2106/JBJS.17.01165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。